Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life.
Nettis E, Brussino L, Patella V, Bonzano L, Detoraki A, Di Leo E, Sirufo MM, Caruso C, Lodi Rizzini F, Conte M, Yacoub MR, Triggiani M, Ridolo E, Macchia L, Rolla G, Brancaccio R, De Paulis A, Spadaro G, Di Bona D, D'Uggento AM, Ginaldi L, Gaeta F, Nucera E, Jaubashi K, Villalta D, Dagna L, Ciotta D, Pucciarini F, Bagnasco D, Celi G, Chieco Bianchi F, Cosmi L, Costantino MT, Crivellaro MA, D'Alò S, Del Biondo P, Del Giacco S, Di Gioacchino M, Di Pietro L, Favero E, Gangemi S, Guarnieri G, Heffler E, Leto Barone MS, Lombardo C, Losa F, Matucci A, Minciullo PL, Parronchi P, Passalacqua G, Pucci S, Rossi O, Salvati L, Schiappoli M, Senna G, Vianello A, Vultaggio A, Baoran Y, Incorvaia C, Canonica GW. Nettis E, et al. Among authors: bonzano l. Clin Mol Allergy. 2022 May 19;20(1):6. doi: 10.1186/s12948-022-00171-2. Clin Mol Allergy. 2022. PMID: 35590407 Free PMC article.
The bacterial lysate Lantigen B reduces the number of acute episodes in patients with recurrent infections of the respiratory tract: the results of a double blind, placebo controlled, multicenter clinical trial.
Braido F, Melioli G, Candoli P, Cavalot A, Di Gioacchino M, Ferrero V, Incorvaia C, Mereu C, Ridolo E, Rolla G, Rossi O, Savi E, Tubino L, Reggiardo G, Baiardini I, di Marco E, Rinaldi G, Canonica GW; Lantigen Study Group; Accorsi C, Bossilino C, Bonzano L, DiLizia M, Fedrighini B, Garelli V, Gerace V, Maniscalco S, Massaro I, Messi A, Milanese M, Peveri S, Penno A, Pizzimenti S, Pozzo T, Raie A, Regina S, Sclifò F. Braido F, et al. Among authors: bonzano l. Immunol Lett. 2014 Dec;162(2 Pt B):185-93. doi: 10.1016/j.imlet.2014.10.026. Epub 2014 Nov 3. Immunol Lett. 2014. PMID: 25445613 Free PMC article. Clinical Trial.
Bilastine: new insight into antihistamine treatment.
Ridolo E, Montagni M, Bonzano L, Incorvaia C, Canonica GW. Ridolo E, et al. Among authors: bonzano l. Clin Mol Allergy. 2015 Apr 15;13(1):1. doi: 10.1186/s12948-015-0008-x. eCollection 2015. Clin Mol Allergy. 2015. PMID: 25878559 Free PMC article.
Dupilumab-Associated Conjunctivitis in Patients With Atopic Dermatitis: A Multicenter Real-Life Experience.
Nettis E, Bonzano L, Patella V, Detoraki A, Trerotoli P, Lombardo C; Italian DADReL (Dupilumab Atopic Dermatitis in Real Life) Study Group. Nettis E, et al. Among authors: bonzano l. J Investig Allergol Clin Immunol. 2020;30(3):201-204. doi: 10.18176/jiaci.0481. Epub 2020 Jan 14. J Investig Allergol Clin Immunol. 2020. PMID: 31932274 Free article. No abstract available.
113 results